NGS樣品製備全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

NGS 樣品製備市場預計將從 2025 年的 33.8 億美元成長到 2034 年的 106.9 億美元，2026 年至 2034 年的複合年成長率為 13.66%。

由於基因組技術在科學研究和臨床應用中的日益普及，全球次世代定序(NGS) 樣品製備市場正經歷快速成長。樣品製備是 NGS 工作流程中的關鍵步驟，可確保定序結果的準確性和可靠性。對個人化醫療和基因檢測日益成長的需求正在推動市場擴張。此外，定序技術的進步也增加了對高效能、高品質樣品製備解決方案的需求。

關鍵成長要素包括基因組研究投入的增加以及新一代定序（NGS）技術在疾病診斷和藥物研發中應用範圍的擴大。樣本製備流程的自動化提高了效率並減少了人為錯誤。 NGS在腫瘤學、感染疾病和罕見遺傳疾病等領域的應用範圍不斷擴大，也促進了市場成長。此外，研究機構和生物技術公司之間的合作正在加速該領域的創新。

未來，隨著基因組學和生物技術的不斷進步，NGS樣本製備市場預計將顯著成長。更快、更經濟的製備技術的開發將提高其可及性。在新興市場，不斷成長的研究活動和醫療保健投資預計將創造巨大的成長機會。此外，人工智慧（AI）和自動化技術的整合將進一步提高工作流程的效率和準確性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球NGS樣品製備市場：依產品與服務分類

• 市場分析、洞察與預測
• 工作站/設備
• 試劑和耗材
• 服務

第5章 全球NGS樣品製備市場：依工作流程分類

• 市場分析、洞察與預測
• DNA片段化與樣品製備
• 靶向序列捕獲
• 品管

第6章 全球NGS樣品製備市場：依樣品類型分類

• 市場分析、洞察與預測
• DNA
• RNA

第7章 全球NGS樣品製備市場：依應用分類

• 市場分析、洞察與預測
• 疾病診斷
• 藥物發現
• 農業和畜牧業調查
• 其他用途

第8章 全球NGS樣品製備市場：依方法分類

• 市場分析、洞察與預測
• 手工樣品製備
• 微流體樣品製備
• 基於自動化液體處理的樣品製備

第9章 全球NGS樣品製備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 學術機構與研究中心
• 製藥和生物技術公司
• 其他最終用戶

第10章 全球NGS樣品製備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Agilent Technologies Inc
  • Danaher Corporation
  • Becton
  • Dickinson And Company
  • QIAGEN NV
  • Merck KGaA
  • Bio-Rad Laboratories Inc
  • Promega Corporation
  • Eurofins Scientific
  • BGI Group
  • 10x Genomics Inc
  • Sysmex Corporation

The NGS Sample Preparation Market size is expected to reach USD 10.69 Billion in 2034 from USD 3.38 Billion (2025) growing at a CAGR of 13.66% during 2026-2034.

The global next-generation sequencing (NGS) sample preparation market is experiencing rapid growth due to the increasing adoption of genomic technologies in research and clinical applications. Sample preparation is a critical step in NGS workflows, ensuring accurate and reliable sequencing results. The growing demand for personalized medicine and genetic testing is driving market expansion. Additionally, advancements in sequencing technologies are increasing the need for efficient and high-quality sample preparation solutions.

Key growth drivers include rising investments in genomics research and the increasing use of NGS in disease diagnosis and drug development. Automation in sample preparation processes is improving efficiency and reducing human error. The expansion of applications in oncology, infectious diseases, and rare genetic disorders is also contributing to market growth. Furthermore, collaborations between research institutions and biotechnology companies are accelerating innovation in this field.

Looking ahead, the NGS sample preparation market is expected to grow significantly with ongoing advancements in genomics and biotechnology. The development of faster and more cost-effective preparation techniques will enhance accessibility. Emerging markets are likely to provide substantial growth opportunities due to increasing research activities and healthcare investments. Additionally, the integration of artificial intelligence and automation will further improve workflow efficiency and accuracy.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Workstations/Instruments
• Reagents & Consumables
• Services

By Workflow

• DNA Fragmentation & Library Preparation
• Target Enrichment
• Quality Control

By Sample Type

• DNA
• RNA

By Application

• Disease Diagnostics
• Drug Discovery
• Agricultural and Animal Research
• Other applications

By Method

• Manual Sample Preparation
• Microfluidic Sample Preparation
• Automated Liquid Handling-based Sample Preparation

By End User

• Hospitals & Clinics
• Academic Institutes & Research Centers
• Pharmaceutical & Biotechnology Companies
• Other End Users

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, PerkinElmer Inc, Agilent Technologies Inc, Danaher Corporation, Becton, Dickinson and Company, QIAGEN NV, Merck KGaA, BioRad Laboratories Inc, Promega Corporation, Eurofins Scientific, BGI Group, 10x Genomics Inc, Sysmex Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NGS SAMPLE PREPARATION MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Workstations/Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NGS SAMPLE PREPARATION MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Workflow
• 5.2. DNA Fragmentation & Library Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Target Enrichment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Quality Control Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NGS SAMPLE PREPARATION MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Sample Type
• 6.2. DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. RNA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NGS SAMPLE PREPARATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Disease Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Agricultural and Animal Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NGS SAMPLE PREPARATION MARKET: BY METHOD 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Method
• 8.2. Manual Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Microfluidic Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Automated Liquid Handling-based Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NGS SAMPLE PREPARATION MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Academic Institutes & Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL NGS SAMPLE PREPARATION MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product & Service
  • 10.2.2 By Workflow
  • 10.2.3 By Sample Type
  • 10.2.4 By Application
  • 10.2.5 By Method
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product & Service
  • 10.3.2 By Workflow
  • 10.3.3 By Sample Type
  • 10.3.4 By Application
  • 10.3.5 By Method
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product & Service
  • 10.4.2 By Workflow
  • 10.4.3 By Sample Type
  • 10.4.4 By Application
  • 10.4.5 By Method
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product & Service
  • 10.5.2 By Workflow
  • 10.5.3 By Sample Type
  • 10.5.4 By Application
  • 10.5.5 By Method
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product & Service
  • 10.6.2 By Workflow
  • 10.6.3 By Sample Type
  • 10.6.4 By Application
  • 10.6.5 By Method
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL NGS SAMPLE PREPARATION INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Illumina Inc
  • 12.2.2 Thermo Fisher Scientific Inc
  • 12.2.3 F. Hoffmann-La Roche Ltd
  • 12.2.4 PerkinElmer Inc
  • 12.2.5 Agilent Technologies Inc
  • 12.2.6 Danaher Corporation
  • 12.2.7 Becton
  • 12.2.8 Dickinson And Company
  • 12.2.9 QIAGEN N.V
  • 12.2.10 Merck KGaA
  • 12.2.11 Bio-Rad Laboratories Inc
  • 12.2.12 Promega Corporation
  • 12.2.13 Eurofins Scientific
  • 12.2.14 BGI Group
  • 12.2.15 10x Genomics Inc
  • 12.2.16 Sysmex Corporation